BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 19242859)

  • 1. Primary (AL) amyloidosis with gastrointestinal involvement.
    Madsen LG; Gimsing P; Schiødt FV
    Scand J Gastroenterol; 2009; 44(6):708-11. PubMed ID: 19242859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous stem-cell transplantation in progressing amyloidosis is associated with severe transplant-related toxicity.
    Worel N; Schulenburg A; Mitterbauer M; Keil F; Rabitsch W; Kalhs P; Gisslinger H; Raderer M; Geissler K; Höcker P; Zielinski CC; Oberbauer R; Greinix HT
    Wien Klin Wochenschr; 2006 Feb; 118(1-2):49-53. PubMed ID: 16489526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.
    Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M;
    Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical recognition of Al type amyloidosis of the luminal gastrointestinal tract.
    James DG; Zuckerman GR; Sayuk GS; Wang HL; Prakash C
    Clin Gastroenterol Hepatol; 2007 May; 5(5):582-8. PubMed ID: 17428737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gastrointestinal amyloidosis in IgG-chi-light chain plasmacytoma. Diagnostic problems despite advanced changes].
    Reithmeier A; Trenkwalder P; Kaess H; Lydtin H
    Dtsch Med Wochenschr; 1995 May; 120(18):641-5. PubMed ID: 7750431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early intensification and autologous stem cell transplantation in patients with systemic AL amyloidosis: a single-centre experience.
    Frossard V; Ketterer N; Rosselet A; Meier P; Cairoli A; Duchosal MA; Kovacsovics T
    Ann Hematol; 2009 Jul; 88(7):681-5. PubMed ID: 19066891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal manifestations of amyloidosis.
    Ebert EC; Nagar M
    Am J Gastroenterol; 2008 Mar; 103(3):776-87. PubMed ID: 18076735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy.
    Lacy MQ; Dispenzieri A; Hayman SR; Kumar S; Kyle RA; Rajkumar SV; Edwards BS; Rodeheffer RJ; Frantz RP; Kushwaha SS; Clavell AL; Dearani JA; Sundt TM; Daly RC; McGregor CG; Gastineau DA; Litzow MR; Gertz MA
    J Heart Lung Transplant; 2008 Aug; 27(8):823-9. PubMed ID: 18656793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment options for severe cardiac amyloidosis: heart transplantation combined with chemotherapy and stem cell transplantation for patients with AL-amyloidosis and heart and liver transplantation for patients with ATTR-amyloidosis.
    Sack FU; Kristen A; Goldschmidt H; Schnabel PA; Dengler T; Koch A; Karck M
    Eur J Cardiothorac Surg; 2008 Feb; 33(2):257-62. PubMed ID: 18096396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal perforation early after peripheral blood stem cell transplantation for AL amyloidosis.
    Schulenburg A; Kalhs P; Oberhuber G; Reiter E; Base W; Greinix HT
    Bone Marrow Transplant; 1998 Aug; 22(3):293-5. PubMed ID: 9720746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal involvement in systemic amyloidosis--an Italian retrospective study on epidemiological and clinical data at diagnosis.
    Bergesio F; Ciciani AM; Santostefano M; Brugnano R; Manganaro M; Palladini G; Di Palma AM; Gallo M; Tosi PL; Salvadori M;
    Nephrol Dial Transplant; 2007 Jun; 22(6):1608-18. PubMed ID: 17395661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The clinical features and outcomes of immunoglobulin light-chain amyloidosis with heart involvement].
    Meng L; Ding WH; Shi LB; Gong YJ; Liu ZP
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Apr; 35(4):340-3. PubMed ID: 17711661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunoglobulin light chain amyloidosis: recent molecular, clinical and therapeutic approach].
    Thierry A; Bridoux F; Goodman H; Belmouaz S; Abou Ayache R; Desport E; Jaccard A; Touchard G
    Nephrologie; 2004; 25(4):111-8. PubMed ID: 15291138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severity of baseline proteinuria predicts renal response in immunoglobulin light chain-associated amyloidosis after autologous stem cell transplantation.
    Leung N; Dispenzieri A; Lacy MQ; Kumar SK; Hayman SR; Fervenza FC; Cha SS; Gertz MA
    Clin J Am Soc Nephrol; 2007 May; 2(3):440-4. PubMed ID: 17699449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tandem cycles of high-dose melphalan and autologous stem cell transplantation increases the response rate in AL amyloidosis.
    Sanchorawala V; Wright DG; Quillen K; Finn KT; Dember LM; Berk JL; Doros G; Fisher C; Skinner M; Seldin DC
    Bone Marrow Transplant; 2007 Sep; 40(6):557-62. PubMed ID: 17589534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review article: gastrointestinal amyloidosis - clinical features, diagnosis and therapy.
    Petre S; Shah IA; Gilani N
    Aliment Pharmacol Ther; 2008 Jun; 27(11):1006-16. PubMed ID: 18363891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful heart transplantation following melphalan plus dexamethasone therapy in systemic AL amyloidosis.
    Mignot A; Bridoux F; Thierry A; Varnous S; Pujo M; Delcourt A; Gombert JM; Goujon JM; Favreau F; Touchard G; Herpin D; Jaccard A
    Haematologica; 2008 Mar; 93(3):e32-5. PubMed ID: 18310532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AL amyloidosis associated with B-cell lymphoproliferative disorders: frequency and treatment outcomes.
    Sanchorawala V; Blanchard E; Seldin DC; O'Hara C; Skinner M; Wright DG
    Am J Hematol; 2006 Sep; 81(9):692-5. PubMed ID: 16795060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney.
    Gertz MA; Leung N; Lacy MQ; Dispenzieri A; Zeldenrust SR; Hayman SR; Buadi FK; Dingli D; Greipp PR; Kumar SK; Lust JA; Rajkumar SV; Russell SJ; Witzig TE
    Nephrol Dial Transplant; 2009 Oct; 24(10):3132-7. PubMed ID: 19403931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soft tissue, joint, and bone manifestations of AL amyloidosis: clinical presentation, molecular features, and survival.
    Prokaeva T; Spencer B; Kaut M; Ozonoff A; Doros G; Connors LH; Skinner M; Seldin DC
    Arthritis Rheum; 2007 Nov; 56(11):3858-68. PubMed ID: 17968927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.